whatshot

CTOR   $1.1400000000000001  -3.39% Market Closed After Close 1.1 -3.51%

Citius Oncology Inc
show_chart Advanced Chart of CTOR

Current temperature: 8.44
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 1
Target Price Mean 3
Mean unverified/preliminary 3 / 3
Target Price Low / High 3 / 3
Median / STD DEV 3 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy ActivelyBuy None
rsi Sell None None
macd None None None
stoch None None None
ma20 Buy Sell None
ma50 ActivelyBuy None None
ma100 Buy ActivelyBuy None
Candlestick PatternJan. 8, 2025 Bearish Three Outside Down - pattern is a made up of three candlesticks. A white candlestick appears on the first day in a uptrend. The second day body engulfs the white body of the first day. A black candlestick on the third day with a lower close than the second day. Considered to be a bearish reversal pattern.
ISIN US17331Y1091
ceo Mr. Leonard L. Mazur
Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York.Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.